Catheter Precision director granted 40,000 stock options
Catheter Precision, Inc. director James Joseph Caruso received a grant of options to buy 40,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Catheter Precision, Inc. director James Joseph Caruso received a grant of options to buy 40,000 shares of common stock. The options have an exercise price of $1.15 per share and expire on March 26, 2036. According to the grant terms, the options vest 100% on the 180-day anniversary of the grant date.
Insider Trade Summary
Grant/Award: 40,000 shares
Grant/Award
1 txn
Insider
Caruso James Joseph
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options (Right to Buy) | 40,000 | $0.00 | $0.00 |
Holdings After Transaction:
Options (Right to Buy) — 40,000 contracts (Direct)
Holdings Before and After:
Options (Right to Buy), 0 to 40,000 contracts (Direct)
Footnotes (1)
- F1. Options vest 100% on 180 day anniversary of grant date.
Key Figures
Options granted: 40,000 options
Exercise price: $1.15 per share
Expiration date: March 26, 2036
+1 more
4 metrics
Options granted
40,000 options
Grant to director James Joseph Caruso on March 26, 2026
Exercise price
$1.15 per share
Strike price for the 40,000 options
Expiration date
March 26, 2036
Option term for director grant
Post-grant derivative holdings
40,000 options
Total options held after the reported transaction
Key Terms
Options (Right to Buy), exercise price, vest 100% on 180 day anniversary, expiration date
4 terms
Options (Right to Buy) financial
"security_title: "Options (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "1.1500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest 100% on 180 day anniversary financial
"Options vest 100% on 180 day anniversary of grant date."
expiration date financial
"expiration_date: "2036-03-26T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VTAK director James Caruso report?
James Joseph Caruso reported receiving options to buy 40,000 shares of Catheter Precision common stock. This was a compensation-related grant, not an open-market purchase, and increases his potential future ownership if the options vest and are exercised.
What is the exercise price of James Caruso’s new VTAK stock options?
The options granted to James Caruso have an exercise price of $1.15 per share. This means he can buy Catheter Precision common stock at $1.15 if he exercises the options after they vest, subject to the grant’s terms and expiration date.
How many VTAK options does James Caruso hold after this Form 4 filing?
Following the reported grant, James Caruso holds 40,000 stock options in Catheter Precision. These options give him the right to purchase an equal number of common shares if exercised, reflecting his full derivative position disclosed in this filing.
When do James Caruso’s Catheter Precision options vest and expire?
The options granted to James Caruso vest 100% on the 180-day anniversary of the grant date. They expire on March 26, 2036, giving a long window for potential exercise once vesting conditions are satisfied under the award terms.
Is James Caruso’s Form 4 for VTAK a stock sale or a grant?
The Form 4 reports a grant of options to James Caruso, classified as an acquisition under transaction code A. It does not disclose any open-market sale or purchase of Catheter Precision common stock, only this new option award position.
AI-generated analysis. How Rhea-AI works. Not financial advice.
